ZA883342B - Diarylalkyl-substituted alkylamines,a process for their preparation,their use,and medicaments containing them - Google Patents

Diarylalkyl-substituted alkylamines,a process for their preparation,their use,and medicaments containing them

Info

Publication number
ZA883342B
ZA883342B ZA883342A ZA883342A ZA883342B ZA 883342 B ZA883342 B ZA 883342B ZA 883342 A ZA883342 A ZA 883342A ZA 883342 A ZA883342 A ZA 883342A ZA 883342 B ZA883342 B ZA 883342B
Authority
ZA
South Africa
Prior art keywords
diarylalkyl
preparation
medicaments containing
substituted alkylamines
alkylamines
Prior art date
Application number
ZA883342A
Other languages
English (en)
Inventor
Rueger Wolfgang
Urbach Hansjoerg
Kaiser Joachim
Original Assignee
Hoechst Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Aktiengesellschaft filed Critical Hoechst Aktiengesellschaft
Publication of ZA883342B publication Critical patent/ZA883342B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Paints Or Removers (AREA)
ZA883342A 1987-05-12 1988-05-11 Diarylalkyl-substituted alkylamines,a process for their preparation,their use,and medicaments containing them ZA883342B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873715763 DE3715763A1 (de) 1987-05-12 1987-05-12 Diarylalkyl-substituierte alkylamine, verfahren zu ihrer herstellung, ihre verwendung sowie sie enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
ZA883342B true ZA883342B (en) 1988-11-16

Family

ID=6327331

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA883342A ZA883342B (en) 1987-05-12 1988-05-11 Diarylalkyl-substituted alkylamines,a process for their preparation,their use,and medicaments containing them

Country Status (14)

Country Link
US (1) US4933346A (da)
EP (1) EP0290958A3 (da)
JP (1) JPS63297358A (da)
KR (1) KR880013893A (da)
CN (1) CN88102650A (da)
AU (1) AU1605588A (da)
DE (1) DE3715763A1 (da)
DK (1) DK259088A (da)
FI (1) FI882177A (da)
HU (1) HUT46897A (da)
IL (1) IL86361A0 (da)
NO (1) NO882065L (da)
PT (1) PT87456B (da)
ZA (1) ZA883342B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0686438B2 (ja) * 1989-03-27 1994-11-02 三菱化成株式会社 アミノベンゼンスルホン酸誘導体
GB9113031D0 (en) * 1991-06-17 1991-08-07 Smithkline Beecham Plc Compounds
WO1993015052A1 (en) * 1992-01-28 1993-08-05 Smithkline Beecham Plc Compounds as calcium channel antagonists
CA2422055A1 (en) 2000-09-11 2002-03-21 Sepracor, Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
SE0103818D0 (sv) 2001-11-15 2001-11-15 Astrazeneca Ab Chemical compounds
SE0301369D0 (sv) 2003-05-09 2003-05-09 Astrazeneca Ab Chemical compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1053301A (da) * 1963-01-14
GB1533383A (en) * 1974-11-15 1978-11-22 Science Union & Cie Arylethers and heterocyclic ethers processes for their preparation and pharmaceutical compositions containing them
GB1546238A (en) * 1976-04-07 1979-05-23 Serdex Soc D Etudes De Rech De Piperazine derivatives a process for their preparation and their applications
CH643549A5 (de) * 1979-08-25 1984-06-15 Merz & Co N-(trimethoxybenzyl)-n'-phenylpiperazine.
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia
DE3529994A1 (de) * 1985-08-22 1987-02-26 Hoechst Ag Indolinonderivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
EP0235463A3 (en) * 1985-12-20 1990-01-17 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) N-substituted-arylalkyl and arylalkylene piperidines as cardiovascular antihistaminic and antisecretory agents
DE3600390A1 (de) * 1986-01-09 1987-07-16 Hoechst Ag Diarylalkyl-substituierte alkylamine, verfahren zu ihrer herstellung, ihre verwendung sowie sie enthaltende arzneimittel

Also Published As

Publication number Publication date
EP0290958A3 (de) 1990-08-08
DE3715763A1 (de) 1988-11-24
US4933346A (en) 1990-06-12
KR880013893A (ko) 1988-12-22
NO882065L (no) 1988-11-14
NO882065D0 (no) 1988-05-11
CN88102650A (zh) 1988-12-14
FI882177A (fi) 1988-11-13
AU1605588A (en) 1988-11-17
DK259088D0 (da) 1988-05-11
JPS63297358A (ja) 1988-12-05
FI882177A0 (fi) 1988-05-10
HUT46897A (en) 1988-12-28
PT87456A (pt) 1989-05-31
DK259088A (da) 1988-11-13
EP0290958A2 (de) 1988-11-17
IL86361A0 (en) 1988-11-15
PT87456B (pt) 1992-09-30

Similar Documents

Publication Publication Date Title
IL81184A0 (en) Diarylalkyl-substituted alkylamines,processes for their preparation,their use,and medicaments containing them
ZA865374B (en) Tertiary hydroxyalkylxanthines,process for their preparation,medicaments containing them and their use
ZA881865B (en) Substituted 9-amino-tetrahydroacridines and related compounds,a process for their preparation and their use as medicaments
ZA886120B (en) New avermectin derivatives,a process for their preparation and their use
ZA903396B (en) N-heteroaryl-4-quinolinamines,a process for their preparation and their use as medicaments
IL83152A0 (en) 7-acyloxy-6-aminoacyloxypolyoxylabdanes,a process for their preparation,and their use as medicaments
ZA882459B (en) New 2-acylpyrrolidine derivatives,a process for their preparation thereof,agents containing them,and their use
IL71856A0 (en) Dibenzodiazepin derivatives,a process for their preparation and their use as medicaments
ZA854287B (en) Dialkoxypyridines,process for their preparation,their use and medicaments containing them
IL85289A0 (en) Alkyl-substituted n-benzopyranyllactams,a process for their preparation,their use,and pharmaceutical preparations based on these compounds
ZA884878B (en) Substituted benzimidazoles,a process for the preparation thereof,pharmaceutical formulations containing them,and the use thereof
IL86361A0 (en) Diarylalkyl-substituted alkylamines,a process for their preparation,their use,and medicaments containing them
ZA861307B (en) New cephalosporins,a process for their preparation,and their use in medicaments
ZA89154B (en) Pyrazol-and indazolpyridin amines,a process for their preparation and their use as medicaments
IL64907A (en) Pyrrolobenzodiazepinones,a process for their preparation,their use,and medicaments containing them
ZA889100B (en) 4-heteroaryl-1,3-benzodiazepines and 2-substituted-alpha-(heteroaryl)benzene-ethanamines,a process for their preparation and their use as medicaments
ZA893374B (en) Hydrazinocarbonyloxylabdanes,a process for their preparation and their use as medicaments
IL84987A0 (en) Nitrohaloalkoxybenzenes,a process for their preparation,and their use
ZA866444B (en) Spergualin-related compounds,a process for their preparation and their use as medicaments
ZA851793B (en) Carboxyalkyldipeptide derivatives,a process for their preparation,agents containing them,and their use
ZA888194B (en) New acyllabdane derivatives,a process for their preparation,and their use as medicaments
ZA882458B (en) Novel pyrrolidine derivatives,a process for their preparation,agents containing these derivatives,and their use
GR860142B (en) (1,2,4-oxadiazol -3- yl) - arylmethanones a process for their preparation and their use as medicaments
NZ220805A (en) Cytorhodin s derivatives,a process for their preparation and their use as medicaments
ZA88756B (en) Alkyl-substituted n-benzopyranyllactams,a process for their preparation,their use,and pharmaceutical preparations based on these compounds